logo
The Global Fund has just made history – now it must start a revolution

The Global Fund has just made history – now it must start a revolution

Mail & Guardian21-05-2025
HIV treatment has, for the first time, been made in Africa.
On 6 May 2025, a quiet revolution took place. The Global Fund to Fight Aids, Tuberculosis and Malaria announced it had, for the first time in its history,
For many outside Africa, this might seem like a footnote in global health procurement logistics. For us on the continent, it is nothing short of history. It's a symbolic and literal act of African solidarity, scientific excellence and economic assertion.
Africa is standing up and saying: 'We will no longer be the last in line for our own survival; we are the source of our own solutions.'
This is not just about pills in blister packs. It is about power, ownership and self-determination in a world where Africa has too often been positioned as a passive recipient of generosity rather than a co-architect of its future.
We are on the cusp of a new era, one where African science, African economies and African futures are not afterthoughts in the global health agenda, but drivers of it.
From political independence to pharmaceutical liberation
Sixty years after many African nations won political independence, the continent is still shackled in economic and technological dependency. Nowhere is this more apparent than in the pharmaceutical sector. Despite bearing the highest burden of HIV globally, Africa has historically relied on imports for between
More than 25 million Africans are living with HIV. Many rely on daily antiretroviral therapy to survive. Ensuring consistent, affordable and sovereign access to these treatments is not optional, it is urgent. But this moment also has implications beyond HIV. It can catalyse African manufacturing in drugs for TB, malaria and non-communicable diseases, vaccines and its pandemic preparedness.
The Global Fund's procurement is the first stone in what could be a continental avalanche of pharmaceutical innovation and a positive step towards the Africa Centres for Disease Control and Prevention's goal to produce 60% of vaccine needs domestically by 2040 through the
From an economic perspective, this move could reshape access to medicines. The benefits of local pharmaceutical production are well-documented but rarely supported at the scale required.
Jobs, cost savings and resilience to health shocks
When medicines are imported, African governments pay not only for the product but also for shipping, import duties and the often-exploitative pricing structures of external manufacturers. Local production, when scaled,
African manufacturers are more likely to understand the price sensitivities of their domestic markets, making them natural allies in the fight for affordable treatment.
When Africa produces at scale, we negotiate from strength. A diversified supply landscape
A robust pharmaceutical sector means more than factories, it means engineers, scientists, quality-assurance professionals, logisticians and educators. It builds a value chain that uplifts entire communities and redirects millions in procurement spend into local economies.
The ripple effect is massive: GDP growth, regional trade and reduced foreign currency outflows.
The Covid-19 pandemic exposed the fragility of international medical supply chains. African countries were left scrambling for vaccines, oxygen and personal protective equipment. By strengthening domestic pharmaceutical capacity, we insulate our public health systems from geopolitical shocks and ensure more consistent access to life-saving drugs.
Four steps to secure systemic change
This procurement cannot remain an isolated incident, a singular success trotted out at conferences and summits. It must spark a movement. A revolution in how global health actors approach access, equity and economic justice in Africa.
Here's what must happen next:
1. Global Fund must make local procurement a permanent policy.
The fund and other major donors, such as Unitaid, must make local sourcing of commodities a default, not a deviation. Pepfar (before Trump got hold of it) was leading the way, aiming for 70% of its funding to go to local partners, but medicines and vaccines were still largely imported.
Policies must be put in place to favour regional production when quality and cost-effectiveness are assured. The success in Kenya should lead to similar procurement from South Africa, Nigeria, Ghana and Senegal, all of which have growing pharmaceutical capabilities.
2. It is time for African governments to move from rhetoric to investment.
Local businesses cannot thrive without local demand. Tax incentives, infrastructure support and subsidies for research and development must be mobilised to grow local pharmaceutical industries. More importantly, governments must commit to procuring from African manufacturers, not only for export, but for national programmes.
3. Regional collaboration must replace national silos.
The African Medicines Agency, operated by the AU, must fast-track regional regulatory harmonisation. This will allow a medicine approved in one country to move freely across borders, removing duplication and accelerating access. A thriving continental pharmaceutical market is only possible if we dismantle bureaucratic barriers.
4. Civil society must hold all stakeholders accountable.
We, the people, cannot afford to be passive in this process. Civil society must monitor procurement decisions, expose backroom deals that favour multinationals and demand transparency in donor policies. Every dollar spent outside Africa, when there is a qualified African supplier is not just lost income, is a political betrayal
We are the generations of return
For centuries, Africa has been mined for its resources, such as gold, diamonds and rubber. Now, the world mines the continent for data, clinical-trial volunteers and intellectual labour. But we are the generations of return. We are bringing back sovereignty to our laboratories, dignity to our procurement systems and power to our people.
This procurement by the Global Fund must be remembered not just as the first time an African-made HIV treatment was purchased, but as the last time it was considered unusual.
It is the beginning of something long overdue — a health system made by us, for us, accountable to us. The symbolism is rich. The politics are radical. The economics are clear.
Let the rest of the world catch up.
Tian Johnson is the founder and strategist of the African Alliance, a pan-African health justice advocacy group.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Motsoaledi urges innovation to end TB
Motsoaledi urges innovation to end TB

The Citizen

time12 hours ago

  • The Citizen

Motsoaledi urges innovation to end TB

Minister of Health, Dr Aaron Motsoaledi, has stressed the urgent need for innovative solutions to combat tuberculosis (TB), a disease that has historically affected not just South Africa but also countries around the world. 'We are here because we believe that TB – a disease that has shaped the history and health of our country and indeed, the whole world – can be ended. Not through words alone, but through action, partnership, and innovation,' he said on Thursday. The Minister was delivering a keynote address at the country's TB Vaccine Preparedness Workshop held in Johannesburg. The workshop is aimed at advancing policy and decision-making for the introduction of TB vaccines. Addressing policymakers, scientists and community leaders, Motsoaledi stated that the upcoming phase will introduce preventative TB vaccination measures, which will also enhance the ongoing fight against HIV and Aids. For over a century, South Africa has relied on the Bacille Calmette-Guérin (BCG) vaccine to protect its children from TB, but the Minister pointed out that there has been no tool that can protect adolescents and adults. 'These are the very groups most at risk of getting sick and transmitting TB.' With several new TB vaccine candidates in the late stages of clinical trials, the most promising options are expected to be available in the next few years. This workshop positioned the country as one of the first that is ready to deliver a new generation of TB vaccines to the most vulnerable populations, including adolescents and adults. The Minister expressed confidence that the upcoming clinical trials would yield positive results, potentially leading to a new vaccine for older age groups within the next few years. TB is a leading cause of death from an infectious disease and a major contributor to ill-health in South Africa and globally. 'Imagine the day when we announce the availability of the vaccine for tuberculosis,' he said, likening it to 'the day of true freedom from slavery' for those suffering from the disease. Motsoaledi described the disease as a form of 'devastating slavery' that exacerbates poverty and leads to premature death. 'South Africa is not waiting for the world to act. We are preparing – intentionally, early and inclusively.' The Minister has used the first national gathering dedicated to the TB vaccine readiness platform to reiterate South Africa's commitment to lead by example in the global fight against TB and HIV. 'When South Africa wins against TB and HIV and Aids the world will win the war,' he said. He told the attendees that through his tenure as Health Minister, he consistently sought to elevate the profile of TB on a global scale. Motsoaledi recalled his 2018 address at the United Nations, where he rallied for world leaders to commit to addressing the TB crisis. 'While global attention has often turned to emerging health threats, South Africa has remained focused on the enduring challenge of TB,' he said. He also acknowledged the disease's severe impact on communities already struggling with HIV. 'Today's discussions remind us that vaccine introduction is not just about science – it is about health systems. It is about trust. It is about readiness.' He also used the platform to emphasise the importance of preparing the health sector for the rollout of the TB vaccine. The agenda for the workshop highlighted key thematic areas crucial for readiness, including generating evidence for policy and investment, strengthening delivery systems for TB vaccines, and ensuring manufacturing and supply chain readiness. 'Investment in human life means everything,' he said, stressing the need for robust financial backing to ensure effective vaccine deployment. The Minister took the time to urge stakeholders to foster community trust and strong advocacy to ensure widespread acceptance of the TB vaccine upon its introduction. 'We must walk the path with our people,' he said. –

The journey from detection to protection: inside South Africa's hepatitis testing gaps
The journey from detection to protection: inside South Africa's hepatitis testing gaps

TimesLIVE

time14 hours ago

  • TimesLIVE

The journey from detection to protection: inside South Africa's hepatitis testing gaps

Egypt showed the world what's possible. Their national hepatitis C programme screened more than 60-million people and treated more than four million — all within five years. This was the result of a public health campaign that brought public and private partners together to inspire a nationwide commitment to eliminating the silent killer. South Africa has the tools, the partnerships and the healthcare workforce to do the same. So why haven't we? Part of the answer lies in awareness. In a recent survey, most South Africans said they didn't know hepatitis was a serious disease. Many had never been offered a test. The virus doesn't always present symptoms early, so it slips beneath the surface — undiagnosed, untreated and unspoken. But another part of the answer lies in how we design our health priorities. Testing for hepatitis still isn't fully integrated into existing services. For example, we've done critical work to normalise HIV testing — it's part of antenatal visits, school programmes, even workplace health drives. Hepatitis should be just as visible. It should be part of every antenatal screening, every STI check-up, every blood drive. Testing for one virus shouldn't mean ignoring others. There's also a missed opportunity in our corporate and community health environments. The burden of hepatitis doesn't stop at the clinic door. Chronic liver disease affects productivity, health budgets and family stability. While specific cost data is limited in South Africa, international evidence is clear: investing in integrated testing and early diagnosis reduces healthcare costs and improves lives. The World Health Organisation has set a goal: eliminate hepatitis as a public health threat by 2030. To get there, South Africa must do three things: Normalise integrated testing for hepatitis B and C. Expand public education to match the scale of the risk. Mobilise partnerships between government, private sector, and civil society to scale up access. Hepatitis isn't rare. It isn't untreatable. And it isn't too late. But every day we wait, we lose lives that could have been saved with a test. Let's not let silence stand in the way of protection. Let's make this the decade where South Africa turns detection into action — and action into health. Everyone deserves to get tested.

Drowning rates in SA go up while global figures drop, says Lifesaving SA
Drowning rates in SA go up while global figures drop, says Lifesaving SA

The Herald

timea day ago

  • The Herald

Drowning rates in SA go up while global figures drop, says Lifesaving SA

Drownings in South Africa are increasing, bucking the global trend where the rates are dropping, Lifesaving South Africa (LSA) warned in a statement to mark World Drowning Prevention Day on Friday. 'While global drowning deaths have dropped by 38% over the past two decades, South Africa's rates are rising,' the federation said, adding the World Health Organisation (WHO) estimated at least 2,700 drowning deaths a year, with children under five at the greatest risk. Africa has seen a 3% decline, while South Africa has struggled to deal with the threat. WHO statistics showed at least 1,600 drowning deaths a year in the country, but these figures did not include deaths from flooding disasters, LSA said. 'In South Africa the crisis is worsened by climate change and flooding disasters, such as those in the Eastern Cape in June, and preventable risks such as unsafe farm dams and canals, inadequate water and sanitation infrastructure and traditional baptism ceremonies at rivers and along coastline.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store